Neha Adlakha | Medicine | Innovative Research Award

Published on by Global Academic Awards

Innovative Research Award

Neha Adlakha, affiliated with Medicine and Dentistry, has been recognized within academic profiling systems for contributions associated with the field of Medicine. This article presents a structured overview of the research profile, publication activity, citation metrics, and scholarly visibility associated with the researcher in relation to the Innovative Research Award and the Global Academic Awards program.[1]

Neha Adlakha
Affiliation Medicine and Dentistry
Country India
Scopus ID 57383386600
Documents 3
Citations 4
h-index 1
Subject Area Medicine
Event Global Academic Awards

Abstract

The Innovative Research Award recognizes scholarly engagement, research dissemination, and academic contribution within specialized scientific domains. The research profile of Neha Adlakha reflects participation in medical research activities documented through indexed publications and citation-based metrics. Academic visibility indicators, including publication count, citations, and h-index values, contribute to the evaluation of research productivity and scholarly impact within the broader scientific community.[1][2]

Keywords

Innovative Research Award, Neha Adlakha, Medicine, Academic Recognition, Research Impact, Scholarly Publications, Citations, h-index, Scopus Author Profile, Global Academic Awards.

Introduction

Academic awards frequently consider measurable research outputs, publication records, and scholarly influence when evaluating candidates. Bibliometric databases such as Scopus provide standardized indicators that assist institutions, organizations, and award committees in assessing scientific contributions. The profile of Neha Adlakha demonstrates documented engagement within the field of Medicine through indexed research outputs and citation activity.[1][3]

Research Profile

Neha Adlakha is associated with Medicine and Dentistry and has established a research profile indexed within international scholarly databases. Available bibliometric indicators report three indexed documents, four citations, and an h-index of one. These metrics provide an overview of scholarly dissemination and the extent to which published research has been referenced by subsequent academic work.[1]

Research profiles maintained within citation databases serve as important resources for identifying research expertise, publication history, and collaboration opportunities. Such profiles contribute to transparency in academic evaluation and support evidence-based assessment of scientific productivity.[2]

Research Contributions

The documented research activities associated with Neha Adlakha contribute to the advancement of medical knowledge through scholarly communication and publication. Contributions reflected within indexed databases indicate engagement with contemporary scientific questions relevant to healthcare, clinical practice, and evidence-based research methodologies.[1]

Research dissemination through peer-reviewed channels enables scientific findings to be evaluated, replicated, and integrated into broader academic discourse. Such contributions support the cumulative development of knowledge across medical and health-related disciplines.[4]

Publications

Publication activity serves as a primary indicator of research dissemination and scholarly engagement. According to available bibliometric information, the researcher has produced three indexed documents. Publication outputs contribute to academic visibility and facilitate knowledge transfer across the scientific community.[1]

The publication record forms an essential component of research evaluation processes and provides evidence of sustained participation in scholarly communication. Indexed publications also enhance discoverability and support citation-based assessments of research influence.[3]

Research Impact

Research impact is frequently evaluated through citation metrics, publication visibility, and engagement within academic literature. The citation count associated with this profile indicates that published work has been referenced within the scholarly record. Citation activity reflects recognition and utilization of research outputs by other investigators.[1][2]

Although bibliometric indicators represent only one dimension of academic influence, they remain widely used in institutional assessments, funding evaluations, and recognition programs focused on research excellence.[2]

Award Suitability

The Innovative Research Award emphasizes scholarly contribution, publication quality, and research engagement. Available indicators associated with Neha Adlakha demonstrate participation in scientific research activities documented through recognized indexing systems. The combination of publications, citation records, and subject-area specialization provides objective information that may support consideration within academic recognition frameworks.[1][5]

Conclusion

Neha Adlakha’s scholarly profile reflects documented participation in medical research through indexed publications and citation activity. Bibliometric indicators available through recognized academic databases provide a measurable foundation for evaluating research dissemination and academic visibility. Within the context of the Innovative Research Award, these indicators contribute to an evidence-based understanding of scholarly achievement and professional engagement within the field of Medicine.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Neha Adlakha, Author ID 57383386600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57383386600
  2. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences.
  3. Elsevier. (n.d.). Scopus Content Coverage Guide and Author Metrics Documentation.
    https://www.elsevier.com/solutions/scopus
  4. The Lancet Editorial Board. (2023). Medical research dissemination and evidence-based practice.
  5. Global Academic Awards. (n.d.). Innovative Research Award Evaluation Framework and Academic Recognition Criteria.
    https://globalacademicawards.com/

รlvaro Castellanos | Medicine | Innovation in Education Excellence Award

Published on by Global Academic Awards

Assoc. Prof. Dr. รlvaro Castellanos | Medicine | Innovation in Education Excellence Award

Assoc. Prof. Dr. รlvaro Castellanos, HOSPITAL UNIVERSITARIO Y POLITร‰CNICO LA FE DE VALENCIA, Spain

Dr. รlvaro Castellanos Ortega is a highly esteemed Associate Professor of Medicine and the Head of the Intensive Care Department at Hospital Universitario y Politรฉcnico La Fe in Valencia. He earned his Medical degree from the University of Valladolid and completed his PhD at the University of Cantabria. With extensive expertise in intensive care and medical education, Dr. Castellanos has contributed significantly to research in infection, sepsis, and training. He has authored 63 indexed publications, and his work on competence-based medical education has earned multiple prestigious awards, including the ESICM Trials Group Award. He is also actively involved in European medical education initiatives.

Publication Profile

Orcid

Professional Qualifications ๐Ÿฅ

Assoc. Prof. Dr. รlvaro Castellanos is a distinguished medical professional with a strong academic and clinical background. He graduated in Medicine and Surgery from the University of Valladolid (1979) and earned his PhD with honors from the University of Cantabria (1998), focusing on a prognostic scoring system for meningococcal septic shock in children. He specialized in Intensive Care Medicine, completing his training at Hospital Universitario Marquรฉs de Valdecilla. Dr. Castellanos serves as Head of the Intensive Care Medicine Department at Hospital Universitario y Politรฉcnico La Fe de Valencia. He is also an Associate Professor at the University of Valencia and an EDIC examiner. Additionally, he holds a Masterโ€™s in Healthcare Administration from the University of Cantabria. ๐ŸŒŸ

 

 

Awards and Recognitions

Assoc. Prof. Dr. รlvaro Castellanos has earned numerous prestigious awards throughout his career. He won the First Prize for Quality Improvement of Care from the Regional Healthcare Service of Cantabria in 2008. His initiative on implementing the Surviving Sepsis Campaign during residency also received recognition. In 2017, he earned the First Prize for Best Patient Safety Initiatives for his rapid response system project. Dr. Castellanos was awarded the Best Project in Postgraduate Teaching by the Lilly Foundation for his electronic portfolio for specialists. Additionally, he received the ESICM Trials Group Award for his research on medical education in intensive care. ๐ŸŒŸ

 

 

Research Focus

Dr. รlvaro Castellanos-Ortega is an Associate Professor with significant contributions in intensive care medicine, particularly related to medical education and patient safety in critically ill patients. He has been involved in multiple research projects focusing on pharmacokinetics in critically ill patients, including studies on Cefiderocol, Isavuconazole, and other medications. Dr. Castellanos-Ortega has authored and co-authored numerous articles on intensive care topics such as COVID-19 management, heart transplantation, and training programs for intensive care medicine. His work is widely published in journals like Medicina Intensiva and Critical Care, contributing significantly to the improvement of clinical practices in intensive care units.

 

 

Publication Top Notes

  • Effect of a Competence-Based Medical Education Program on Training Quality in Intensive Care Medicine. COBALIDATION TRIAL.
    Medicina Intensiva (2025-01-03)
    DOI: 10.1016/j.medine.2024.502126
    PMID: 39755447
    Contributors: Castellanos-Ortega ร, Broch Porcar MJ, Palacios-Castaรฑeda D, et al.
  • Cefiderocol Pharmacokinetics in Critically Ill Patients Undergoing ECMO Support.
    Critical Care (2024-10-18)
    DOI: 10.1186/s13054-024-05126-4
    PMID: 39425201
    PMC: PMC11488226
    Contributors: Marรญn-Cerezuela M, Martรญn-Latorre R, Frasquet J, et al.
  • Reply to “Patient Safety, What Does Clinical Simulation and Teaching Innovation Contribute?”
    Medicina Intensiva (2024-10-05)
    DOI: 10.1016/j.medine.2024.07.013
    PMID: 39368886
    Contributors: Broch Porcar MJ, Castellanos-Ortega ร
  • Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends Over Time.
    Biomedicines (2024-09-16)
    DOI: 10.3390/biomedicines12092109
    PMID: 39335622
    PMC: PMC11428817
    Contributors: Lรณpez Vilella R, Pรฉrez Guillรฉn M, Borja Guerrero Cervera, et al.
  • Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.
    Antibiotics (2024-07-29)
    DOI: 10.3390/antibiotics13080706
    PMID: 39200006
    PMC: PMC11350865
    Contributors: Martรญn Cerezuela M, Gallegos C, Marquรฉs-Miรฑana MR, et al.
  • Patient Safety, What Does Clinical Simulation and Teaching Innovation Contribute?
    Medicina Intensiva (2024-05-25)
    DOI: 10.1016/j.medine.2024.04.012
    PMID: 38797620
    Contributors: Broch Porcar MJ, Castellanos-Ortega ร
  • “INTUPROS”: An Opportunity to Reflect Upon and Improve.
    Medicina Intensiva (2024-05-06)
    DOI: 10.1016/j.medine.2024.04.014
    PMID: 38714391
    Contributors: Viviani A, Vicent C, Castellanos-Ortega ร
  • Mentoring Programme: Guiding Your First Steps Towards Scientific Excellence.
    Medicina Intensiva (2023-03-21)
    DOI: 10.1016/j.medine.2023.03.006
    PMID: 36948924
    Contributors: Lobo-Valbuena B, Galarza Barrachina L, Albillos Almaraz R, et al.
  • Effects of Intubation Timing in Patients with COVID-19 Throughout the Four Waves of the Pandemic: A Matched Analysis.
    The European Respiratory Journal (2023-03-02)
    DOI: 10.1183/13993003.01426-2022
    PMID: 36396142
    PMC: PMC9686319
    Contributors: Riera del Brio J, Barbeta E, Tormos A, et al.
  • Driving Pressure and Adjunctive Therapies in Pulmonary Sequelae of COVID-19 Patients Under Invasive Ventilation.
    Intensive Care Medicine (2023-01-25)
    DOI: 10.1007/s00134-022-06951-3
    PMID: 36695836
    PMC: PMC9875751
    Contributors: Gonzรกlez J, Ivรกn David Benรญtez, Ana Motos, et al.

 

Miguel Virseda-Chamorro | Medicine and Dentistry | Best Researcher Award

Published on by Global Academic Awards

Dr. Miguel Virseda-Chamorro | Medicine and Dentistry | Best Researcher Award

Dr. Miguel Virseda-Chamorro, Hospital Nacional de paraplรฉjicos, Spain

Dr. Miguel Virseda-Chamorro is a distinguished urologist with extensive expertise in urodynamics and pelvic floor disorders. He earned his MD from the University of Valencia in 1981 and specialized in Urology at Gรณmez Ulla Hospital in 1990. He holds a PhD, awarded cum laude in 1992, and completed further education in Health Sciences Statistics. Dr. Virseda is a Fellow of the European Board of Urology and has contributed to major scientific journals. Recognized with several prestigious awards, his research has impacted functional urology and neurogenic bladder treatment. He is fluent in multiple languages and an active member of several urological societies. ๐Ÿฅ๐Ÿงฌ๐Ÿ“Š

Publication Profile

Scopus

Orcid

Academic Formation and Specializations

Dr. Virseda-Chamorro has an impressive academic trajectory, beginning with a Licenciatura in Medicine and Surgery from the University of Valencia (1981) and multiple specialized courses in Urology and Medical Aeronautics. He has also pursued advanced degrees, including a Master in Health Sciences Design and Statistics (2001), which supports his clinical research. His PhD in Urology, awarded with distinction, further underscores his expertise in the field.

Awards and Distinctions

His outstanding contributions have been recognized through several prestigious awards, such as the Best Doctoral Thesis Awards (1992, 1995), and multiple honors from the Spanish Urology Association for his groundbreaking research. These recognitions validate his impact on the field of urology, particularly in areas like urodynamic models and pelvic prolapse treatment.

Teaching and Clinical Trials

Dr. Virseda-Chamorro has also made significant contributions to medical education, leading various courses on pelvic floor treatment and urodynamic pediatric pathologies. His participation in numerous clinical trials, such as evaluating the efficacy of beta-3 agonists for overactive bladder, shows his ongoing commitment to advancing medical knowledge and patient care.

Conclusion

Dr. Miguel Virseda-Chamorroโ€™s rich academic background, clinical expertise, significant research contributions, and numerous honors make him an ideal candidate for the Best Researcher Award. His dedication to both clinical practice and advancing scientific understanding in urology highlights his qualification for this prestigious recognition.

 

Publication Top Notes

  • Can We Differentiate Between Organic and Functional Bladder Outlet Obstruction in Males With Parkinson’s Disease? (2024)ย  ๐Ÿง ๐Ÿ“…
  • Factors Influencing Postoperative Overactive Bladder after Adjustable Trans-Obturator Male System Implantation for Male Stress Incontinence following Prostatectomy (2023) – 1 citation ๐Ÿ’‰๐Ÿ“…
  • Update on Adjustable Trans-Obturator Male System (ATOMS) for Male Incontinence after Prostate Cancer Surgery (2023) – 4 citations ๐Ÿฆ ๐Ÿ“…
  • ATOMS in Patients with Post-Prostatectomy Incontinence and Previously Treated Urethral Stricture or Bladder Neck Contracture (2022) – 6 citations ๐Ÿšป๐Ÿ“…
  • Functional Changes during the Voiding Phase in Men with Non-Neurogenic Detrusor Underactivity Undergoing Bladder Catheterization (2022)ย  ๐Ÿงฌ๐Ÿ“…
  • Compression or Obstruction: Analysis of the Function of ATOMS Based on Pre- and Postoperative Urodynamic Data (2022) – 4 citations ๐Ÿ› ๏ธ๐Ÿ“…
  • Urodynamics of Urinary Retention in Guillain-Barrรฉ Syndrome Post-Infection by SARS-CoV-2 (2022) – 1 citation ๐ŸŒ๐Ÿ“…
  • Influence of ATOMS Implant on the Voiding Phase of Patients with Post-Prostatectomy Urinary Incontinence (2022) – 3 citations ๐Ÿšฝ๐Ÿ“…
  • Prevalence and Risk Factors for Lower Urinary Tract Symptoms after Robotic Sacrocolpopexy (2021) – ๐Ÿค–๐Ÿ“…
  • Long-term Outcome of ATOMS for Stress Urinary Incontinence in the Iberian Multicentre Study (2020) – 17 citations ๐Ÿ“Š๐Ÿ“…

 

 

 

 

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Published on by Global Academic Awards

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Dr Cristina Papayannidis, IRCCS, Azienda Ospedaliero Universitaria S.Orsola Malpighi, Bologna, Italy, Italy

Dr. Cristina Papayannidis appears to be an outstanding candidate for the Best Researcher Award based on several key criteria:

Publication profile

scopus

Extensive Experience

Dr. Papayannidis has been deeply involved in clinical research and patient care in hematology since her early career. Her role as Dirigente Medico Ematologia at IRCCS Azienda Ospedaliero Universitaria di Bologna highlights her leadership in AML and ALL clinical trials.

High Research Output

She has authored over 130 publications and has been a principal or sub-investigator in more than 60 phase 1-3 clinical trials, showcasing her significant contributions to advancing hematology research.

Recognition and Influence

With an H-index of 34, she has made substantial impacts in her field. Her role as a speaker at over 300 national and international events, including prestigious conferences like ASH and EHA, underscores her influential presence in the hematological community.

Mentorship and Leadership

Her positions as a mentor in EHA Master Classes and member of various working groups demonstrate her commitment to guiding the next generation of researchers and shaping the future of hematology.

Professional Memberships

  1. Memberships in esteemed organizations such as SIE, EHA, and AACR, and her role on the Hematological Malignancies Committee ESMO further reflect her prominent status and active participation in the scientific community.

Dr. Papayannidisโ€™s extensive research experience, high publication volume, significant impact on clinical practice, and active involvement in mentorship and professional societies make her a highly suitable candidate for the Best Researcher Award.

 

Research focus
The research focus of the individuals associated with these articles centers on hematological malignancies and their management. They investigate advanced treatments and strategies for diseases like acute lymphoblastic leukemia (ALL), particularly in the context of drug therapies and stem cell transplantation. Key topics include evaluating the efficacy of ponatinib versus imatinib in treating Philadelphia chromosome-positive ALL, using ponatinib to prevent relapse after transplantation, and assessing the impact of inotuzumab ozogamicin on outcomes and complications in refractory cases. Their work contributes to improving therapeutic approaches and patient outcomes in hematology. ๐Ÿฉบ๐Ÿ’‰๐Ÿ”ฌ

Publication top notes

Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)

Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission โ€ 

Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease

Zhenhan Deng | Medicine and Dentistry | Best Researcher Award

Published on by Global Academic Awards

Zhenhan Deng | Medicine and Dentistry | Best Researcher Award

Dr Zhenhan Deng, The First Affiliated Hospital of Wenzhou Medical University, China

Dr. Zhenhan Deng is a distinguished orthopedic surgeon born on July 19, 1989. He currently serves as a Deputy Chief Physician at The First Affiliated Hospital of Wenzhou Medical University in China ๐Ÿ‡จ๐Ÿ‡ณ. Dr. Deng completed his Ph.D. at Xiangya Hospital, CSU, and was a visiting scholar at the University of Texas Health Science Center ๐Ÿฅ. His research focuses on osteoarthritis and cartilage regeneration, supported by significant grants and notable publications ๐Ÿ“š. He has received multiple awards, including the Orthopaedic Research Society’s New Investigator Recognition Award and the Shenzhen Health Elite Talent title ๐ŸŒŸ. For more details, visit his official website ๐ŸŒ.

Publication profile

google scholar

Education

Deng pursued his Ph.D. in Orthopedics at Xiangya Hospital, Central South University (CSU), Hunan, China, from September 2015 to November 2018. Additionally, he was a Visiting Scholar at the University of Texas Health Science Center at Houston, focusing on Orthopedics, from December 2016 to September 2018. Prior to his doctoral studies, Deng completed his Master of Medicine and Bachelor of Medicine degrees at Xiangya Hospital, CSU.

Work Experience

Throughout his career, Deng has held various positions in orthopedic surgery and sports medicine. He served as a Deputy Chief Physician in the Department of Orthopedic Surgery at The First Affiliated Hospital of Wenzhou Medical University from December 2023 to September 2023. Prior to this, he worked as an Attending Physician in the same department. Deng also gained experience as an Attending Physician in the Department of Sports Medicine at Shenzhen Second People’s Hospital, Shenzhen, Guangdong, China, from September 2020 to September 2023, after starting as a Resident Physician in December 2018.

Awards

Deng has received numerous awards and honors for his contributions to orthopedic research and clinical practice. Notable accolades include being nominated for the Orthopaedic Research Society (ORS) New Investigator Recognition Awards (NIRA), winning the Orthopaedic Research Society (ORS) ON Foundation/ORS Orthoregeneration Award, and receiving recognition as an Outstanding Graduate of Hunan Province.

Research focus

Zhenhan Deng is an orthopaedic surgeon and researcher focused on advancing treatments for musculoskeletal conditions, particularly osteoarthritis and cartilage repair. His research encompasses the development of innovative therapies, such as microgel scaffolds, mesenchymal stem cells, and gene therapy to promote cartilage regeneration and joint repair. Dengโ€™s work includes investigating the roles of various signaling pathways in disease progression and treatment efficacy. His projects and publications underscore his commitment to improving patient outcomes through cutting-edge, translational medical research. ๐Ÿฉบ๐Ÿฆด๐Ÿงฌ๐Ÿ”ฌ๐Ÿ’ก๐ŸŒŸ

For further information, you can visit his personal work website at https://dzhdr.haodf.com/.

Publication top notes

  1. Electrical stimulation for pain relief in knee osteoarthritis: systematic review and network meta-analysis
    C Zeng, T Yang, Z Deng, Y Yang, Y Zhang, G Lei
    Osteoarthritis and Cartilage, 2015 – 179 citations ๐Ÿ“Š
  2. Effectiveness of continuous and pulsed ultrasound for the management of knee osteoarthritis: a systematic review and network meta-analysis
    C Zeng, H Li, T Yang, ZH Deng, Y Yang, Y Zhang, X Ding, GH Lei
    Osteoarthritis and Cartilage, 2014 – 158 citations ๐Ÿ“‰
  3. Macrophages in osteoarthritis: pathophysiology and therapeutics
    Y Chen, W Jiang, H Yong, M He, Y Yang, Z Deng, Y Li
    American Journal of Translational Research, 2020 – 118 citations ๐Ÿฆ 
  4. Bone morphogenetic proteins for articular cartilage regeneration
    ZH Deng, YS Li, X Gao, GH Lei, J Huard
    Osteoarthritis and Cartilage, 2018 – 103 citations ๐Ÿ’‰
  5. The role of sirtuin 1 and its activator, resveratrol in osteoarthritis
    Z Deng, Y Li, H Liu, S Xiao, L Li, J Tian, C Cheng, G Zhang, F Zhang
    Bioscience Reports, 2019 – 97 citations ๐Ÿ‡
  6. Long noncoding RNAs in osteoarthritis
    J Lu, Z Deng, Y Li, G Lei
    Joint Bone Spine, 2017 – 88 citations ๐Ÿงฌ
  7. Cartilage tissue engineering: From proinflammatory and antiโ€‘inflammatory cytokines to osteoarthritis treatments
    S Liu, Z Deng, K Chen, S Jian, F Zhou, Y Yang, Z Fu, H Xie, J Xiong, …
    Molecular Medicine Reports, 2022 – 86 citations ๐Ÿฆด
  8. Is posterior tibial slope associated with noncontact anterior cruciate ligament injury?
    C Zeng, T Yang, S Wu, S Gao, H Li, Z Deng, Y Zhang, G Lei
    Knee Surgery, Sports Traumatology, Arthroscopy, 2016 – 81 citations ๐Ÿƒโ€โ™‚๏ธ
  9. Characterization of a novel polyvinyl alcohol/chitosan porous hydrogel combined with bone marrow mesenchymal stem cells and its application in articular cartilage repair
    L Peng, Y Zhou, W Lu, W Zhu, Y Li, K Chen, G Zhang, J Xu, Z Deng, …
    BMC Musculoskeletal Disorders, 2019 – 73 citations ๐Ÿ’ง
  10. Association between dietary magnesium intake and radiographic knee osteoarthritis
    C Zeng, H Li, J Wei, T Yang, Z Deng, Y Yang, Y Zhang, T Yang, G Lei
    PLoS One, 2015 – 70 citations ๐Ÿฝ๏ธ
  11. RhoA/ROCK pathway: implication in osteoarthritis and therapeutic targets
    Z Deng, Y Jia, H Liu, M He, Y Yang, W Xiao, Y Li
    American Journal of Translational Research, 2019 – 67 citations ๐Ÿ”ฌ
  12. MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376A
    W Luo, H He, W Xiao, Q Liu, Z Deng, Y Lu, Q Wang, Q Zheng, Y Li
    Oncotarget, 2016 – 65 citations ๐ŸŽฏ
  13. Alterations of amino acid metabolism in osteoarthritis: its implications for nutrition and health
    Y Li, W Xiao, W Luo, C Zeng, Z Deng, W Ren, G Wu, G Lei
    Amino Acids, 2016 – 63 citations ๐Ÿฝ๏ธ
  14. Modified arthroscopic Latarjet procedure: suture-button fixation achieves excellent remodeling at 3-year follow-up
    J Xu, H Liu, W Lu, Z Deng, W Zhu, L Peng, K Ouyang, H Li, D Wang
    The American Journal of Sports Medicine, 2020 – 58 citations ๐Ÿ…
  15. MicroRNA-199a-5p inhibits cisplatin-induced drug resistance via inhibition of autophagy in osteosarcoma cells
    Y Li, W Jiang, Y Hu, Z Da, C Zeng, M Tu, Z Deng, W Xiao
    Oncology Letters, 2016 – 53 citations ๐Ÿšซ
  16. MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targetting EIF4G2
    X Xie, YS Li, WF Xiao, ZH Deng, HB He, Q Liu, W Luo
    Bioscience Reports, 2017 – 51 citations ๐Ÿ›ก๏ธ
  17. MicroRNA-127-5p regulates osteopontin expression and osteopontin-mediated proliferation of human chondrocytes
    M Tu, Y Li, C Zeng, Z Deng, S Gao, W Xiao, W Luo, W Jiang, L Li, G Lei
    Scientific Reports, 2016 – 50 citations ๐Ÿงซ
  18. p38MAPK signaling pathway in osteoarthritis: pathological and therapeutic aspects
    Z Li, A Dai, M Yang, S Chen, Z Deng, L Li
    Journal of Inflammation Research, 2022 – 45 citations ๐ŸŒก๏ธ
  19. Diet-intestinal microbiota axis in osteoarthritis: a possible role
    Y Li, W Luo, Z Deng, G Lei
    Mediators of Inflammation, 2016 – 45 citations ๐Ÿ”—
  20. Relationship between cigarette smoking and radiographic knee osteoarthritis in Chinese population: a cross-sectional study
    Y Zhang, C Zeng, H Li, T Yang, Z Deng, Y Yang, X Ding, D Xie, Y Wang, …
    Rheumatology International, 2015 – 45 citations ๐Ÿšฌ

Each line provides the title of the paper, the authors, the journal it was published in, the year of publication, the number of citations, and an emoji representing the general theme or content of the paper.

Yora Mostmans | Medicine | Best Researcher Award

Published on by Global Academic Awards

Dr. Yora Mostmans | Medicine | Best Researcher Awardย 

Dr. Yora Mostmans, ULB, Belgium

Dr. Yora Mostmans is a distinguished dermatologist specializing in immunology and allergology. Graduating with honors from Vrije Universiteit Brussel, she pursued extensive research on histamine receptors and cysteinyl leukotriene receptors in dermatoses. With a passion for patient care and research, she completed residencies at renowned institutions such as UZ Brussel and CHU Brugmann. Dr. Mostmans holds a diploma in Dermatology and Venereology and is currently pursuing a PhD at Universitรฉ Libre Bruxelles. Her work focuses on microcirculatory involvement in inflammatory skin diseases.

Publication Profile:

Scopus

Education :

Dr. Yora Mostmans embarked on her academic journey at Sint-Pieterscollege in Jette, Brussels, where she completed her high school education with a focus on Science and Mathematics. With a thirst for knowledge and a dedication to the field of medicine, she pursued her Bachelor’s degree in medicine at Vrije Universiteit Brussel (VUB), excelling and graduating with distinction. Her passion and commitment continued as she delved deeper into her studies, earning her Master’s degree in medicine magna cum laude, further solidifying her expertise in the field.During her educational journey, Dr. Mostmans sought enriching experiences through specific internships, including stints in Internal Medicine and Pediatrics at the Aga Khan Hospital in Dar Es Salaam, Tanzania, and Dermatology at CHU Saint Louis in Paris, France. These internships not only broadened her clinical knowledge but also instilled in her a global perspective on healthcare.Dr. Mostmans’ academic achievements culminated in her research thesis, “The role of histamine receptors and cysteinyl leukotriene receptors in epidermal permeability homeostasis and inflammatory dermatoses,” which earned her the highest honors, summa cum laude.With her diverse educational background and international experiences, Dr. Mostmans is now dedicated to making a meaningful impact in the field of dermatology, blending clinical expertise with a deep understanding of dermatological research. ๐Ÿ“šโš•๏ธ

Teaching and Training Experience:

Dr. Yora Mostmans is not only a dedicated clinician but also a passionate educator with a wealth of teaching and training experience. From her early years as a tutorship in anatomy at Vrije Universiteit Brussel (VUB) to her current role as a supervisor for dermatology trainees, she has consistently shared her expertise and knowledge with the next generation of medical professionals.Her commitment to medical education extends to bedside teaching, where she imparts valuable insights to medical students on the dermatology department at UZ Brussel. Additionally, she has served as a mentor for several thesis projects, guiding students in their research endeavors on topics such as chronic urticaria.As a speaker for the “Certificate for international interuniversitary course Immunology-Allergology” at ULB Brussels, Dr. Mostmans has contributed to the education of fellow professionals, particularly in the dermatology module focusing on chronic urticaria.Through her teaching and training experiences, Dr. Mostmans not only fosters the growth of aspiring medical professionals but also advances the understanding and treatment of dermatological conditions. ๐Ÿ“–๐Ÿ‘ฉโ€๐Ÿซ

Certificates & Courses:

Dr. Yora Mostmans has actively pursued further education and certification to refine her expertise. Notable achievements include completing a Capillaroscopy course organized by Actelion in October 2014, and obtaining a Certificate of Good Clinical Practice through online training courses in January 2014 and February 2017. Her dedication to excellence is evident in passing the EULAR systemic sclerosis online course with an impressive 85% in June 2016, and earning a certificate from the EULAR capillaroscopy course in January 2017. Dr. Mostmans excelled in the international interuniversity course in Immunology-Allergology at ULB Brussels, graduating summa cum laude with a thesis on paraneoplastic lupus. Currently, she continues her learning journey with an ongoing EULAR capillaroscopy course. ๐Ÿ“š๐ŸŽ“

Research Focus:

Dr. Yora Mostmans is a dermatologist whose research primarily focuses on microcirculatory changes in chronic spontaneous urticaria and systemic sclerosis. Through various studies and publications, she investigates the clinical profiles, treatment strategies, and diagnostic tools for these dermatological conditions, utilizing techniques such as capillaroscopy and videocapillaroscopy. Dr. Mostmans also explores the involvement of endothelial cells and the coagulation system in chronic urticaria, contributing to a better understanding of the pathophysiology of this condition. Her research endeavors aim to enhance diagnostic accuracy, improve patient care, and advance knowledge in the field of dermatology. ๐Ÿฉบ๐Ÿ”ฌ

Publication Top Notes:

Chronic spontaneous urticaria: Evidence of systemic microcirculatory changes

Flemish network on rare connective tissue diseases (CTD): patient pathways in systemic sclerosis. First steps taken

Chronic Spontaneous Urticaria in Belgium: Deciphering the Clinical Profile and Treatment of Patients Visiting an Urban City Immunology Department

A port-wine stain mimicking secondary Raynaudโ€™s phenomenon in a phototype V patient: clinical and videocapillaroscopic evaluation

Standardized nailfold capillaroscopy in children with rheumatic diseases: A worldwide study

Nailfold videocapillaroscopy and serum vascular endothelial growth factor in probable COVID-19-induced chilblains: a cross-sectional study to assess microvascular impairment

 

 

 

 

 

 

 

 

Erica Pietroluongo | Medicine | Young Scientist Award

Published on by Global Academic Awards

Dr. Erica Pietroluongo | Medicine | Young Scientist Award

Dr. Erica Pietroluongo, University of Naples Federico II, Italy

๐Ÿ‘ฉโ€โš•๏ธ Dr. Erica Pietroluongo is a dedicated oncologist and researcher based in Naples, Italy. With an MD from the University of Naples Federico II and ongoing PhD studies in Advanced Biomedical and Surgical Therapies, she specializes in medical oncology, particularly in rare tumors. Dr. Pietroluongo is actively involved in various professional societies, including the American Society of Clinical Oncology and the International Thymic Malignancy Working Group. Her research focuses on improving treatment personalization in breast cancer and investigating bioumoral determinants in SARS-Cov-2-infected patients with thymic epithelial tumors. She also contributes to teaching and training future medical professionals.

Publication Profile:

Scopus

Orcid

Education:

๐Ÿ“š Dr. Erica Pietroluongo pursued her passion for medicine at the University of Naples Federico II, where she earned her MD in Medicine. With a strong foundation in healthcare, she embarked on a journey of continuous learning, currently immersing herself in the realm of research as a PhD student in Advanced Biomedical and Surgical Therapies. Under the guidance of Prof. F Pane at the Department of Clinical Medicine and Surgery, University of Naples Federico II, she delves into cutting-edge studies. ๐ŸŽ“ Committed to advancing medical knowledge, Dr. Pietroluongo’s dual roles as a physician and researcher epitomize her dedication to enhancing patient care and outcomes.

Teaching and Training:

๐Ÿ“ Dr. Erica Pietroluongo is deeply committed to advancing her skills in clinical research and teaching methodologies. In April 2023, she participated in a Medical Writing Course organized by the Italian Society of Surgery in Campobasso, in collaboration with prestigious institutions like Springer Nature and the University of Naples Federico II. This course equipped her with essential writing skills vital for disseminating research findings effectively. Moreover, in June 2023, she further honed her expertise as an “Expert in Evaluation and Facilitation of Regional Oncology Networks” through a program facilitated by AGENAS, the National Agency for Health Regional Services. ๐ŸŒŸ These training initiatives underscore Dr. Pietroluongo’s commitment to enhancing her capabilities and contributing to the advancement of healthcare practices.

Research Focus:

๐Ÿ” Dr. Erica Pietroluongo’s research focus primarily revolves around two key areas: thymic epithelial tumors and breast cancer. In her studies on thymic epithelial tumors, she explores the impact of SARS-Cov-2 mRNA vaccines on patients’ immune responses and seroconversion. Additionally, she investigates the potential diagnostic role of miRNAs in breast cancer, particularly miRNA-27a and miRNA-128, packaged in extracellular vesicles. Her work not only sheds light on the immunological responses to COVID-19 vaccines in cancer patients but also aims to identify novel biomarkers for improved diagnosis and prognosis in breast cancer. Dr. Pietroluongo’s research contributes significantly to both oncology and immunology fields. ๐ŸŽฏ

Publication Top Notes:

Serum biomarkers of inflammation and vascular damage upon SARS-Cov-2 mRNA vaccine in patients with thymic epithelial tumors

miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer

Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors

 

 

 

 

 

 

 

Songรผl ร‡uฤŸlan | Medicine | Best Researcher Award

Published on by Global Academic Awards

Assist Prof Dr. Songรผl ร‡uฤŸlan | Medicine | Best Researcher Award

Assist Prof Dr. Songรผl ร‡uฤŸlan, ฤฐstanbul Beykent University, Faculty of Medicine, Turkey

๐Ÿ‘ฉโ€๐Ÿ”ฌ Prof. Dr. Songรผl ร‡uฤŸlan is an accomplished anatomist and educator, born on September 10, 1985, in Malatya. Holding a joint Ph.D. from ฤฐnรถnรผ University and Fฤฑrat University, she specializes in anatomy research, particularly focusing on fetal development and the effects of environmental factors. With extensive experience in academia, including roles as Head of Anatomy Department and lecturer, Dr. ร‡uฤŸlan has contributed significantly to projects investigating formaldehyde exposure and organ development. Her work has been recognized through numerous publications and awards, reflecting her dedication to advancing medical education and understanding human anatomy.

Publication Profile:

Scopus

Orcid

Awards:

๐Ÿ† Prof. Dr. Songรผl ร‡uฤŸlan, a distinguished anatomist and educator, earned recognition for her exceptional contribution to research at the 15th National Anatomy Congress held in Samsun from September 5-8, 2013. Together with her esteemed colleagues, including Sapmaz HI, Polat A, Vardฤฑ N, Kรถse E, and Tanbek K, Dr. ร‡uฤŸlan received the Best Poster Award for their study titled “Investigation of the healing effects of black cumin oil on the changes caused by formaldehyde inhalation in rat testicles.” This accolade underscores her commitment to advancing scientific knowledge in the field of anatomy and her dedication to exploring innovative solutions to complex medical challenges. Dr. ร‡uฤŸlan’s achievement reflects her expertise in conducting impactful research that has practical implications for understanding the effects of environmental factors on biological systems. As an esteemed member of the anatomy community, she continues to inspire colleagues and students alike through her passion for discovery and her unwavering pursuit of excellence in anatomical research. This award serves as a testament to her outstanding contributions and underscores her position as a leader in the field. ๐ŸŒŸ

Courses:

๐Ÿ‘ฉโ€๐Ÿซ Prof. Dr. Songรผl ร‡uฤŸlan has actively contributed to the advancement of anatomical knowledge through her involvement in organizing courses and congresses. In 2013, she served as a Course Organizing Committee Member for the 1st Stereological Methods Course held in Malatya. This course provided valuable insights into advanced techniques for quantifying biological structures in three-dimensional space, fostering a deeper understanding of anatomical research methodologies. Dr. ร‡uฤŸlan’s participation in organizing this event demonstrates her commitment to facilitating educational opportunities and promoting the dissemination of cutting-edge scientific techniques within the academic community.Furthermore, her dedication to academic leadership was evident at the 16th National Anatomy Congress in Malatya, held from September 11-14, 2014, where she served as a Congress Organizing Committee Member. This prestigious event brought together leading experts and scholars in the field of anatomy to exchange ideas, present research findings, and discuss emerging trends in anatomical education and research. Dr. ร‡uฤŸlan’s role in organizing the congress highlights her role as a key figure in fostering collaboration and knowledge-sharing among anatomists nationwide. Her contributions to these events underscore her commitment to advancing anatomical education and research, cementing her reputation as a respected leader in the field. ๐ŸŒ

AdministrativeDuties:

๐Ÿ‘ฉโ€๐Ÿ’ผ Prof. Dr. Songรผl ร‡uฤŸlan has demonstrated exceptional leadership in various administrative roles within the academic community. Since March 2020, she has served as the Head of the Anatomy Department, overseeing its strategic direction and academic activities. Additionally, from January 2021 to January 2024, Dr. ร‡uฤŸlan held the position of 2nd Term 3 Coordinatorship, managing coordination efforts within the department. Previously, she served as the President of the Tissue-Organ Systems Introduction Board (4.D.K.) from 2019 to 2021 and as the President of the Circulatory, Blood, and Respiratory Systems Course Committee (2nd DK) during the same period. Her dedication to administrative duties highlights her commitment to enhancing the academic experience and promoting excellence in anatomical education. ๐Ÿ“š

Research Focus:

๐Ÿ”ฌ Prof. Dr. Songรผl ร‡uฤŸlan’s research focus spans diverse areas within anatomical and biomedical sciences, showcasing a multidisciplinary approach to understanding human biology and pathology. Her studies delve into critical topics such as the protective efficacy of natural compounds against environmental toxins, anatomical variations with clinical implications, and the relationship between anthropometric measurements and respiratory health in patients with chronic obstructive pulmonary disease (COPD). Through her contributions to journals like the Asian Pacific Journal of Tropical Biomedicine and the Nigerian Journal of Basic and Clinical Sciences, Dr. ร‡uฤŸlan illuminates novel insights that contribute to the advancement of medical knowledge and patient care. ๐ŸŒฑ

Publication Top Notes:

The relationship between anthropometric measurements and modified mallampati test in patients with chronic obstructive pulmonary disease

Protective efficacy of Nigella sativa oil against the harmful effects of formaldehyde on rat testicular tissue

Corona mortis: in vivo anatomical knowledge and the risk of injury in totally extraperitoneal inguinal hernia repair

 

 

 

 

 

 

Islam Mohammad Shehata | Medicine | Best Researcher Award

Published on by Global Academic Awards

Dr. Islam Mohammad Shehata | Medicine | Best Researcher Award

Dr. Islam Mohammad Shehata, Ain Shams University, Egypt

Dr. Islam Mohammad Shehata is a Cardiothoracic Anesthesiologist with diverse international experience. He earned his Doctoral degree in Anesthesiology in August 2022 and holds a European diploma in the field. Dr. Shehata completed a Visiting Scholarship in Cardiothoracic Anesthesia at The Ohio State University in 2019. Currently, he serves as a Cardiothoracic Consultant Anesthesiologist at the Ministry of Interior Hospital in Cairo, Egypt, and is an Assistant Lecturer at Ain Shams University Faculty of Medicine. With a wealth of expertise, he actively contributes to conferences and workshops, emphasizing hemodynamic monitoring and regional anesthesia. ๐ŸŒ๐Ÿ‘จโ€โš•๏ธ

Publication Profile:

Orcid

Google Scholar

Education:

Dr. Islam Mohammad Shehata is a highly qualified anesthesiologist, holding a diverse range of educational achievements. He pursued a Visiting Scholarship in Cardiothoracic Anesthesia at The Ohio State University College of Medicine from April to August 2019, enriching his international experience. In August 2022, he successfully attained his Doctoral degree in Anesthesiology. Additionally, he holds a European diploma in Anesthesiology and Intensive Care, awarded in March 2022, and a Master’s degree in Anesthesiology obtained in November 2014. Dr. Shehata completed his Residency at Ain Shams University School of Medicine, Cairo, from July 2012 to June 2015, after earning his MD in March 2010 from the same institution. ๐ŸŽ“๐Ÿ‘จโ€โš•๏ธ

Professional Experience:

Dr. Islam Mohammad Shehata is a distinguished anesthesiologist with a rich professional journey. Currently serving as an Assistant Lecturer at Ain Shams University Faculty of Medicine since November 2015, he has contributed significantly to the clinical department of Anesthesiology. In 2019, he broadened his expertise during a Visiting Scholarship as an anesthesiologist at Ohio State University, Wexner Medical Center. Dr. Shehata holds key roles as a Cardiothoracic Consultant Anesthesiologist at the Ministry of Interior Hospital and the Egyptian Railway Medical Center. His dedication extends to leading the Liver Transplant team at Ain Shams University Specialized Hospital and serving as a Cardiothoracic Attending Anesthesiologist at both Air Force Specialized Hospital and El Dorra Cardiac Center. ๐Ÿฅ๐Ÿ‘จโ€โš•๏ธ

Research Focus:

Dr. Islam Mohammad Shehata is a dedicated anesthesiologist with a significant research focus on critical aspects of cardiac surgery, pain management, and the impact of COVID-19 on elective procedures. His work explores topics such as intraoperative hypotension, pulmonary embolism, and cardiac tamponade in COVID-19 patients, highlighting the role of telemedicine in developing countries. Dr. Shehata contributes valuable insights to anesthesia literature, addressing challenges in lung isolation, hyperinflated native lung management, and the use of ultrasonography in bariatric surgery. His commitment to advancing medical knowledge is evident in his publications, providing a comprehensive understanding of anesthesia in diverse clinical scenarios. ๐Ÿ“š๐Ÿ‘จโ€โš•๏ธ

Publication Top Notes:

    1. Elective cardiac surgery during the COVID-19 pandemic: Proceed or postpone? ๐Ÿ“‘ Cited by: 26, Year: 2020
    2. Acupuncture for the Management of Low Back Pain ๐Ÿ“‘ Cited by: 14, Year: 2021
    3. Pulmonary embolism and cardiac tamponade in critical care patients with COVID-19; telemedicineโ€™s role in developing countries: case reports and literature review ๐Ÿ“‘ Cited by: 13, Year: 2021
    4. Telemedicine, e-health, and multi-agent systems for chronic pain managementnt ๐Ÿ“‘ Cited by: 11, Year: 2023
    5. Postoperative management of hyperinflated native lung in single-lung transplant recipients with chronic obstructive pulmonary disease: a review article ๐Ÿ“‘ Cited by: 10, Year: 2021
    6. Con: Routine use of the hypotension prediction index in cardiac, thoracic, and vascular surgery ๐Ÿ“‘ Cited by: 6, Year: 2021
    7. A Comprehensive Review and Update of the Use of Dexmedetomidine for Regional Blocks ๐Ÿ“‘ Cited by: 4, Year: 2020
    8. Mitral regurgitation in patients undergoing noncardiac surgery๐Ÿ“‘ Cited by: 3, Year: 2022
    9. Preoperative, Multidisciplinary Clinical Optimization of Patients with Severely Depressed Left Ventricular Ejection Fraction Who Are Undergoing Coronary Artery Bypass Grafting ๐Ÿ“‘ Cited by: 3, Year: 2021
    10. Intraoperative Hypotension Increased Risk in the Oncological Patient ๐Ÿ“‘ Cited by: 3, Year: 2021
    11. Lung Isolation in the Setting of Vocal Cord Implantation ๐Ÿ“‘ Cited by: 2, Year: 2022

Stephen Holgate | Medicine | Best Researcher Award

Published on by Global Academic Awards

Prof. Stephen Holgate | Medicine | Best Researcher Award

Prof. StephenHolgate, University of Southampton, United Kingdom

Prof. Stephen Holgate, a distinguished figure, has been associated with the University of Southampton Faculty of Medicine since 1975, where he currently serves. ๐ŸŽ“ He earned his BSC in Medicine from the same institution in 1968. ๐Ÿฅ Prof. Holgate’s extensive career showcases his commitment to advancing medical knowledge and education. His enduring affiliation with Southampton reflects a lifelong dedication to medical research and teaching. ๐ŸŒ With a foundation laid in 1967, he continues to contribute significantly to the field, leaving an indelible mark on the academic and medical community.

Publication Profile:

Orcid

Google Scholar

๐ŸŽ“Education and qualifications:

Prof. Stephen Holgate’s academic journey is deeply rooted in the prestigious University of Southampton, where he pursued a Bachelor of Science (BSC) within the Faculty of Medicine. ๐Ÿฅ Commencing in September 1967 and concluding in September 1968, his dedicated year of study laid the foundation for a remarkable career. ๐ŸŽ“ Prof. Holgate’s educational endeavors at Southampton reflect his early commitment to the field of medicine. This pivotal period not only equipped him with foundational knowledge but also marked the beginning of a lifelong association with the university, shaping his trajectory as a distinguished figure in medical research and academia. ๐ŸŒŸ

๐ŸŒEmployment :

Since August 1, 1975, Prof. Stephen Holgate has been an unwavering pillar of the University of Southampton Faculty of Medicine in Southampton, GB. ๐Ÿฅ His enduring commitment spans decades, contributing significantly to the institution’s academic and medical landscape. As a distinguished member of the faculty, Prof. Holgate’s work encompasses research, teaching, and shaping the next generation of medical professionals. ๐ŸŽ“ His dedication to the University of Southampton is not merely a tenure but a testament to his profound impact on medical education and research. Through his continued presence, Prof. Holgate exemplifies a legacy of excellence that extends beyond the confines of time. ๐ŸŒ

๐Ÿ†Research Focus:

Prof. Stephen Holgate’s prolific research focuses on the intersection of air pollution and health, delving into critical aspects of respiratory medicine. ๐ŸŒฌ๏ธ With over five decades of impactful contributions, he has explored diverse themes, including viral infections in asthma, the role of interleukins, and the genetic underpinnings of bronchial hyperresponsiveness. ๐Ÿฆ  His groundbreaking work extends to understanding the inflammatory responses in asthma, airway remodeling, and the intricate immune dynamics involved. ๐Ÿงฌ Prof. Holgate’s dedication to unraveling the complexities of respiratory conditions has positioned him as a leading authority, shaping the discourse on asthma, allergy, and the environmental factors influencing respiratory health. ๐Ÿ†

๐Ÿ“šPublication Top Notes:

  1. Air pollution and health
    • ๐Ÿ”„ Cited by 5350 (2002)
  2. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
    • ๐Ÿ”„ Cited by 4375 (2020)
  3. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children
    • ๐Ÿ”„ Cited by 2492 (1995)
  4. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
    • ๐Ÿ”„ Cited by 2306 (2000)
  5. Exposure to House-Dust Mite Allergen (Der pย I) and the Development of Asthma in Childhood: A Prospective Study
    • ๐Ÿ”„ Cited by 2160 (1990)
  6. Mucosal Inflammation In Asthma1. 2
    • ๐Ÿ”„ Cited by 1719 (1990)
  7. Mast-cell infiltration of airway smooth muscle in asthma
    • ๐Ÿ”„ Cited by 1578 (2002)
  8. Association of theย ADAM33ย gene with asthma and bronchial hyperresponsiveness
    • ๐Ÿ”„ Cited by 1563 (2002)
  9. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus
    • ๐Ÿ”„ Cited by 1485 (2005)
  10. Cellular events in the bronchi in mild asthma and after bronchial provocation
    • ๐Ÿ”„ Cited by 1481 (2012)